Bookeditor, Ronald M. Bukowski.
Contents:
Targeted therapy for renal cell carcinoma / Ronald M. Bukowski
Overview of renal cell carcinoma pathways and drug targets / Bernard Escudier
mTOR in renal cell cancer: modulator of tumor biology and therapeutic target / Piotr J. Wysocki
VEGF inhibitors / Toni K. Choueiri & Ali R. Golshayan
VEGFR/PDGFR inhibitors in RCC / Jean S.Z. Lee & Tim Eisen
Next-generation immunotherapy: CTLA-4 and PD-1 inhibitors / Daniel Y.C. Heng
EGF receptor inhibitors / Marine Gross-Goupil & Alain Ravaud
Cytokines / Alexandra Leary, James M.G. Larkin & Lisa M. Pickering
Vaccination / Robert J Amato
Evidence-based therapy of non-clear-cell and sarcomatoid renal cell carcinoma / Elan Diamond, Naveed H. Akhtar, Scott T. Tagawa & David M. Nanus
Bisphosphonates in renal cell carcinoma: palliation versus antitumor effects / Saby George & Roberto Pili
Combination therapy and future directions in renal cell carcinoma / Bernard Escudier & Camillo Porta.